Unlocking Insights, Driving Access: Bridging Real-World Evidence to Market Success in Europe
This gathering serves a platform where industry leaders, healthcare professionals, and policymakers converge to explore the latest trends, challenges, and innovations shaping the dynamic landscape of evidence-based healthcare and market access strategies. Through engaging keynotes, interactive panel discussions, and networking opportunities, this event aims to foster collaboration, share best practices, and catalyze advancements that drive improved patient outcomes and successful market access across the European healthcare ecosystem.
WHAT TO EXPECT
Key Highlights
- Updates on European regulatory frameworks governing real-world evidence (RWE) and their impact on market access strategies.
- Ensuring the reliability, validity, and relevance of RWE in the context of market access.
- Effective collaboration strategies between industry stakeholders and payers to enhance market access outcomes.
- Strategies for pricing and reimbursement that align with evidence-based market access approaches.
- The impact of patient-reported outcomes on demonstrating product value and effectiveness.
- The role of health economics in demonstrating the economic value of healthcare interventions.
Why Attend?
- Learn about the recent trends and advancements in Real-World Evidence Generation
- Engage in meaningful discussion with the most prominent industry experts and decision makers from pharmaceutical and biopharmaceutical companies who will address most critical challenges in real-world data and real-world evidence space.
- Opportunity to network and exchange scientific knowledge with expert speakers from leading pharmaceutical companies, global regulators and solution providers
Agenda
Day 1
Registration - 08:15 - 09:00
Welcome note - 09:00 - 09:05
Opening remarks by the Chairperson - 09:05 - 09:10
Data Quality and Standardization
Ensuring the reliability and quality of real-world data used in RCTs. - 09:10 - 09:40
RWE in the EU Joint Clinical Assessment- Opportunities and Challenges?
Sandeep Kiri, UCB Global Payer Value Strategy- Head of Health Economics and HTA Evidence, UCB - 09:40 - 10:10
Electronic Health Record meets Evidence
Ralf Patsch, Head of Real-World Data Business Germany, Cegedim - 10:10 - 10:40
Morning Refreshments and Poster Presentation - One-to-One Networking Meeting - 10:40 - 11:30
RWE for Health Technology Assessment (HTA)
Sponsor Presentation - Slot Reserved for Gold/Silver Sponsors- Flatiron - 11:30 - 12:00
Role of RWE in supporting HTA submissions - 12:00 - 12:30
Lewis Carpenter, Director Real World Evidence, Arcturis Data - 12:30 - 13:00
Lunch and Poster Presentation - One-to-One Networking - 13:00 - 14:00
Post-Marketing Surveillance and Phase IV Trials
Leveraging real-world evidence for post-approval monitoring. - 14:00 - 14:30
Sponsor Presentation - Slot Reserved for Silver/Bronze Sponsors - 14:30 - 15:00
Panel Discussion- RWE in assessing long-term safety and effectiveness of interventions. - 15:00 - 15:40
Evening Refreshments and Poster Presentation - One-to-One Networking - 15:40 - 16:25
Patient Recruitment and Retention
Strategies for recruiting and retaining diverse patient populations - 16:25 - 16:55
Closing remarks by the Chair Chairperson. - 16:55 - 17:25
Drinks Reception and Networking .....END OF DAY 1..... - 17:25 - 17:50
Day 2:
Registration - 08:15 - 08:50
Welcome note - 08:50 - 09:05
Opening remarks by the Chairperson - 09:05 - 09:10
Patient-Centric Market Access
Utilizing patient-reported outcomes (PROs) and patient-centric RWE - 09:10 - 09:40
Sponsor Presentation - Slot Reserved for Gold / Silver Sponsors - 09:40 - 10:10
Engaging patients in the market access process - 10:10 - 10:45
Morning Refreshments and Poster Presentation - One-to-One Networking - 10:45 - 11:30
RWE in Market Access for Rare Diseases
Unique challenges and opportunities in demonstrating value for rare disease treatments - 11:30 - 12:40
Sponsor Presentation - Slot Reserved for Bronze Sponsors - 12:40 - 12:40
Navigating pricing and reimbursement considerations for orphan drugs - 12:40 - 13:10
Closing remarks by the chairperson - 13:10 - 13:15
Lunch and Poster Presentation - One-to-One Networking - 13:15 - 13:15
Speakers
Helene Vioix
Director Global Evidence & Value Development Oncology, Merck KGaA
Inha Kim
Vice President, Head of Global Strategy and Communication, Medical Affairs,, Lundbeck
Vandana Ayyar-Gupta
Scientific Adviser, Data & Analytics, National Institute for Health, and Care Excellence
Iroda Jurabekova
Global Pricing and Market Access Lead, Boehringer Ingelheim
Nivedita Valentine
Global Associate Vice President, Product Innovation, Pharmanovia
Ralf Patsch
Head of Real-World Data Business Germany, Cegedim
Senior Representative, Flatiron Health
Senior Representative, Cascador Health
Senior Representative, Numerus
Sandeep Kiri
UCB Global Payer Value Strategy- Head of Health Economics and HTA Evidence, UCB
Lewis Carpenter
Director Real World Evidence, Arcturis Data
Gustavo Olivera
HEOR (Health Economics & Outcomes Research) Senior Expert, Sanofi
Craig Currie
Honorary Professor of Pharmacoepidemiology, Cardiff University
Rocío Casado Seminario
European Affairs and Evidence Generation Head, , European Cancer Organisation (ECO)
Sabrina de Souza
Associate Director, Real World Data Scientist (CMS, PRWE), Merck
Who Should Attend
From pharmaceutical and Biopharmaceutical companies
Chief executives, VP’s, Directors, Global heads, Heads, Leaders, Senior Managers, Researcher, Analysts, Investigators, Scientists within the following departments-
- Real-World Evidence
- Real-World Data
- Data Analytics
- Health Economics & Outcomes Research- HEOR
- Market Access/Value Access
- Policy
- Clinical Development & Research
- Clinical trial
- Centre for Observational and Real-World Evidence
- Epidemiology
- Oncology-RWE
- Pricing and Reimbursement
- Medical Affairs
- Pharmacovigilance
- Life Science Analytics
- Big data
- Data Science
- Bio-Statistics
- Consumer Healthcare
Other
Payers, Regulators, Research Institutes, and Innovation Centre
Location
ADDRESS
Freiburg im Breisgau
Germany
Venue to be announced shortly.
